XML 145 R131.htm IDEA: XBRL DOCUMENT v3.10.0.1
Supplemental Condensed Consolidating Financial Information (Schedule of Condensed Consolidating Statement of Cash Flows) (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities:      
Net cash (used in) provided by operating activities $ 274 $ 773 $ 1,137
Cash flows from investing activities:      
Acquisitions of facilities and other related businesses (26) (6) (123)
Purchases of property and equipment (527) (564) (744)
Proceeds from disposition of hospitals and other ancillary operations 405 1,692 143
Proceeds from sale of property and equipment 8 7 15
Purchases of available-for-sale securities and equity securities (78) (125) (505)
Proceeds from sales of available-for-sale securities and equity securities 114 208 464
Proceeds from sale of investments in unconsolidated affiliates     403
Distribution from Quorum Health Corporation     1,219
Increase in other investments (141) (143) (242)
Net cash (used in) provided by investing activities (245) 1,069 630
Cash flows from financing activities:      
Repurchase of restricted stock shares for payroll tax withholding requirements (1) (5) (6)
Deferred financing costs and other debt-related costs (96) (66) (26)
Proceeds from noncontrolling investors in joint ventures 3 5  
Redemption of noncontrolling investments in joint ventures (31) (6) (19)
Distributions to noncontrolling investors in joint ventures (96) (100) (92)
Proceeds from sale-lease back     159
Borrowings under credit agreements 28 841 4,879
Issuance of long-term debt 1,033 3,100  
Proceeds from ABL and receivables facility 797 105 107
Repayments of long-term indebtedness (2,033) (5,391) (6,715)
Net cash used in financing activities (396) (1,517) (1,713)
Net change in cash and cash equivalents (367) 325 54
Cash and cash equivalents at beginning of period 563 238 184
Cash and cash equivalents at end of period 196 563 238
Parent Guarantor [Member]      
Cash flows from operating activities:      
Net cash (used in) provided by operating activities 40 (12) 14
Cash flows from financing activities:      
Repurchase of restricted stock shares for payroll tax withholding requirements (1) (5) (6)
Changes in intercompany balances with affiliates, net (39) 17 (8)
Net cash used in financing activities (40) 12 (14)
Issuer [Member]      
Cash flows from operating activities:      
Net cash (used in) provided by operating activities (409) (317) (335)
Cash flows from investing activities:      
Distribution from Quorum Health Corporation     1,219
Increase in other investments (7)    
Net cash (used in) provided by investing activities (7)   1,219
Cash flows from financing activities:      
Deferred financing costs and other debt-related costs (96) (65) (26)
Changes in intercompany balances with affiliates, net 99 1,565 801
Borrowings under credit agreements   795 4,848
Issuance of long-term debt 1,033 3,100  
Proceeds from ABL and receivables facility 748    
Repayments of long-term indebtedness (1,368) (5,078) (6,507)
Net cash used in financing activities 416 317 (884)
Other Guarantor [Member]      
Cash flows from operating activities:      
Net cash (used in) provided by operating activities 319 727 1,074
Cash flows from investing activities:      
Acquisitions of facilities and other related businesses (3) (1) (99)
Purchases of property and equipment (410) (367) (476)
Proceeds from disposition of hospitals and other ancillary operations 185 596 14
Proceeds from sale of property and equipment 2 4 6
Purchases of available-for-sale securities and equity securities (54) (91) (263)
Proceeds from sales of available-for-sale securities and equity securities 79 172 218
Proceeds from sale of investments in unconsolidated affiliates     403
Increase in other investments (109) (106) (156)
Net cash (used in) provided by investing activities (310) 207 (353)
Cash flows from financing activities:      
Deferred financing costs and other debt-related costs   (1)  
Changes in intercompany balances with affiliates, net 207 (437) (708)
Proceeds from sale-lease back     147
Borrowings under credit agreements 28 30 30
Proceeds from ABL and receivables facility 49 105 107
Repayments of long-term indebtedness (657) (291) (193)
Net cash used in financing activities (373) (594) (617)
Net change in cash and cash equivalents (364) 340 104
Cash and cash equivalents at beginning of period 499 159 55
Cash and cash equivalents at end of period 135 499 159
Non-Guarantor Subsidiaries [Member]      
Cash flows from operating activities:      
Net cash (used in) provided by operating activities 324 375 384
Cash flows from investing activities:      
Acquisitions of facilities and other related businesses (23) (5) (24)
Purchases of property and equipment (117) (197) (268)
Proceeds from disposition of hospitals and other ancillary operations 220 1,096 129
Proceeds from sale of property and equipment 6 3 9
Purchases of available-for-sale securities and equity securities (24) (34) (242)
Proceeds from sales of available-for-sale securities and equity securities 35 36 246
Increase in other investments (25) (37) (86)
Net cash (used in) provided by investing activities 72 862 (236)
Cash flows from financing activities:      
Proceeds from noncontrolling investors in joint ventures 3 5  
Redemption of noncontrolling investments in joint ventures (31) (6) (19)
Distributions to noncontrolling investors in joint ventures (96) (100) (92)
Changes in intercompany balances with affiliates, net (267) (1,145) (85)
Proceeds from sale-lease back     12
Borrowings under credit agreements   16 1
Repayments of long-term indebtedness (8) (22) (15)
Net cash used in financing activities (399) (1,252) (198)
Net change in cash and cash equivalents (3) (15) (50)
Cash and cash equivalents at beginning of period 64 79 129
Cash and cash equivalents at end of period $ 61 $ 64 $ 79